High-density lipoprotein (HDL) cholesterol, total cholesterol, and triglyceride concentrations were measured in fasting blood samples from 74 controls and 185 patients with untreated primary hyperlipoproteinaemia. The mean HDL cholesterol levels and the total cholesterol :HDL cholesterol ratios were significantly different between male and female subjects. Only patients with Fredrickson type IV hyperlipoproteinaemia had HDL cholesterol concentrations significantly lower than the controls, but all subjects with hyperlipoproteinaemia had total :HDL cholesterol ratios significantly higher than control values.
The inverse relation between the plasma concentration of high-density lipoprotein (HDL) and the incidence of coronary heart disease is now well documented.vf In monitoring the treatment of patients with hyperlipoproteinaemias it has therefore been emphasised that HDL should be estimated as an additional factor in determining the risk of heart dlsease." The ideal treatment would most likely result in a lowering of concentration of the atherogenic low-density lipoprotein (LDL) and very lowdensity lipoprotein (VLDL) classes, while giving an increase in the concentration of HDL. Physical activity, moderate alcohol consumption, and certain lipid-lowering drugs will elevate HDL but may also be associated with adverse changes in other lipoprotein fractions; for example, clofibrate will decrease VLDL and increase HDL in type IV hyperlipoproteinaemia but it may also cause an undesirable rise in LDL. 7 The effects of various diets on the levels of blood lipids are variable.
This study investigates the serum level of HDL cholesterol in patients with untreated primary hyperlipoproteinaemias of Fredrickson types IIa, lIb, and IV and presents preliminary data on the responses of non-hospitalised subjects to treatment by diet alone or in combination with clofibrate.
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Methods
During the 18 months of the study 185 patients (137 men and 48 women) were referred to the department by general practitioners, or after outpatient consultations, for full investigation of their newly diagnosed hyperlipoproteinaemia (fasting serum lipid concentrations above laboratory reference ranges for age and sex) and before the beginning of any treatment. After an overnight fast, blood was drawn from a forearm vein, and the serum was stored at 4°before analysis, usually within four days (maximum 10 days). Serum triglyceride and total cholesterol concentrations were estimated by fully enzymatic methods (Boehringer Corporation (London) Limited, cat. no. 1664488, and BDH Chemicals Limited, cat. no. 250482V, respectively) . HDL cholesterol was measured in the same way after precipitation of LDL and VLDL by sodium phosphotungstate/magnesium chloride (final concentrations 3' 6 gIl and 45 mmol/l, respectlvely)." Classification of the hyperlipoproteinaemia was made according to the WHO modification of Fredrickson's criteria" after electrophoretic separation in agarose. change with age, although the ratio in women with type IIa in the fifth decade was lower due to the increased HDL cholesterol noted above ( Fig. 3 ).
Of the four women in the sixth decade with type lIb disease, the mean ratio of 3 fell within the range of the younger patients. However, the fourth patient had a ratio of 14·3 due to a high total cholesterol, and if she is included the mean rises considerably as shown ( Fig. 3 ). Of 31 patients reviewed after treatment, the initially elevated lipids were lowered in 21 cases (Fig. 4 ). Only four type IIa subjects were investigated during the study period, dietary controls alone reducing the total cholesterol concentration in three with little change in triglyceride. The total: HDL cholesterol ratio was reduced from an increased level in two cases and remained normal in the third, whose HDL cholesterol fell slightly. Of the eight patients with type IV disease, triglyceride n=48 n=14 n=19 n=15~C ontrols pa~l~ts D~redriCk~~n type IV Fig. 1 Distribution (mean and range) 0/ HDL cholesterol (a), total cholesterol (e), and total:HDL cholesterol ratio (D) among control subjects and hyperlipoprotelnaemic patients. P (Student's t test): patients compared with control group:" < 0·05, "<0·001. n = number ofsubjects in group. women) of similar age to the patients, but without overt lipid or cardiovascular disorders, was studied to provide reference ranges.
A review was made of 31 patients after treatment for the hyperlipoproteinaemia over periods of two to 12 months. For subjects with Fredrickson type IIa hyperlipoproteinaemia the diet was modified to be low in saturated fatty acids while polyunsaturated fatty acids were increased. Cholesterol intake was restricted. These modifications were repeated for type lIb patients with an additional restriction on carbohydrate intake. In type IV patients, fat and carbohydrate were restricted, and increased body weights were reduced towards normal. Some patients also took clofibrate in addition to the dietary measures (type Ilb, two subjects Ig daily and one subject 2g daily; type IV, three subjects 1·5 g daily).
The distribution of HDL cholesterol values in the control group and in patients at the time of their initial investigations is shown in Figure 1 . The mean concentrations for men (1'24, SD 0'24 mrnol/l) and women (1'47, SD 0·32 mmol/I) in the control group are similar to those found by others,lO-12 the significantly higher values obtained for women (p<O·Ol) being consistent with previous findings.
The mean concentrations of HDL cholesterol in all patients, irrespective of sex (men I· 11, SD O'28 mmol/l; women 1'39, SD 0'36 mmol/l) were lower than the control values, the difference being significant for men (p<0·05). When the Fredrickson classes are considered individually, only the patients in type IV have significantly decreased concentrations (p<O'OOI men, p<0'05 women).
There is controversy as to whether the level of HDL cholesterol varies with age. [10] [11] [12] In this study the patients were subdivided according to age and Fredrickson type, as shown in Figure 2 . There was generally no significant variation in HDL cholesterol between the age ranges studied for any of the hyperlipoproteinaemia groups, although women in their fifth decade with type IIa disease had a mean concentration above that of the other age groups. However, this group consisted of only three patients.
The distributions of the total :HDL cholesterol ratio among controls and patients are shown in Figure 1 . The mean ratios for men (4' 89, SD I '14) and women (4'13, SO 1, 11) in the control group are significantly different (p<0'05) and similar to published values.P Patients of each sex in all Fredrickson groups had ratios significantly higher than their respective controls (Fig. 1 ), type IIb values being the greatest. There was no consistent :z: 6 0 .... 5 cholesterol concentrations" of 3· 5 mrnol/l or less increased on treatment. When the patients are grouped together only the fall in triglyceride concentration is significant (Table) . The 19 subjects with type lIb hyperlipoproteinaemia showed variable responses to treatment, lowering of both triglyceride and total cholesterol occurring in 12. Of these, eight had a concurrent reduction of total :HDL cholesterol ratio, although the HDL cholesterol increased in only five. If the results for the 11 men patients are grouped together (Table) the reduction in ratio is probably significant (p<O'05), although the increase in HDL cholesterol is not. The responses of patients taking clofibrate in addition to dietary restrictions could not be separated from those treated by dietary modifications alone.
Discussion
The mean levels of HDL cholesterol found in the control subjects are similar to those published previously, with significantly higher values in women. I D-12 Although most patient groups had lower mean concentrations than the controls, only the decreases in those with Fredrickson type IV hyperlipidaemia were significant. This is in accord with the known inverse relationship between HDL cholesterol and VLDL, although there is controversy as to whether the decrease in HDL cholesterol reflects a true lowering of HDL mass or Sale and Johnstone a displacement of cholesterol esters from the apoproteins by triglyceride. u 18 Various workers I 2 I S have shown that relating the HDL cholesterol to the total serum cholesterol concentration, either as a total: HDL cholesterol ratio or by expressing HDL cholesterol as a percentage of the total concentration, gives an equal, if not better, prediction of risk from coronary heart disease than HDL cholesterol alone. The control subjects in this study had mean total: HDL cholesterol ratios of 4· 89 for men and 4·13 for women, similar to the figures associated with an average risk in Castelli's study, 13 Patients in all our groups had mean ratios significantly higher than these, the smallest increases being found in type IV disease and the largest in type lIb.
The numbers of patients reviewed after initiation of treatment for their hyperlipoproteinaemia are too small to allow definitive conclusions. However, when the patients are considered individually some comments are pertinent, although not generally confirmed statistically when the groups are taken as a whole. In type IV subjects, reduction of triglyceride will usually be accompanied by an increase in HDL cholesterol. This agrees with previous findings," although Elkeles found no increases in his subjects." However, if the LDL cholesterol concentration was initially below about 3·5 mmol/l this will also rise according to the pattern reported by Carlson et al.,' and the potential danger of this response is reflected in the increased total: HDL cholesterol ratio in these patients after treatment. The ratio tends to decrease with successful treatment of type IIa patients due to the lower concentration of total cholesterol with unchanged or increased HDL cholesterol. The effect of treatment on type lIb subjects is more variable.
The HDL cholesterol was increased in 42 % of the patients, decreased in 42 %, and unchanged in 16%t the response being independent of reductions in triglyceride or total cholesterol. However, the total: HDL cholesterol ratio was reduced in 84% of patients owing to the combined effect of changes in both cholesterol fractions. The changes in patients taking clofibrate in addition to the dietary regime were similar to the responses with diet alone, and it is not possible to ascribe any specific effects to the drug in this study. Successful lowering of cholesterol an-I triglyceride by conventional means in hyperlipoproteinaemias of Fredrickson types Ila, Ilb, and IV thus appears generally to result in a decrease in the total: HDL cholesterol ratio, although not always due to an increase in the HDL cholesterol fraction. Whether such a modification of the ratio may be equated with a reduction in the risk of developing coronary heart disease has yet to be established.
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